「etc.news」の検索結果
65件：36～40件目を表示
-
千寿製薬株式会社
NEWS & RELEASE September 4, 2025 Senju has developed and obtained approval for a BAC-free formulation of Aibeta® combination eye drops（PDF） March 7, 2025 Announcement of Licensing Agreement with B
http://www.senju.co.jp/english/ -
Research and Development System | Research & Development | SENJU Pharmaceutica
All things in nature have a reason for being. Today’s common sense is not common sense tomorrow. This is our motto. Senju Pharmaceutical has unique research systems, such as international joint resear
http://www.senju.co.jp/english/rd/about/ -
Product Development Policy | Research & Development | SENJU Pharmaceutica
Corporate Strategy DivisionProduct Planning DepartmentDirectorYasunobu Maenaka With the management philosophy of “Good Company” and a company that shapes “Beyond eyesight,” we have developed products
http://www.senju.co.jp/english/rd/policy/ -
Mytear EYETECT | OTC Products, etc. | Products | SENJU Pharmaceutical
Category 2 OTC medicines Mytear® EYETECT® For teary eye, foreign body sensation CHARACTERISTICS Mytear EYETECT includes the anti-inflammatory ingredient, pranoprofen [swich OTC Drug], and is effective
https://www.senju.co.jp/english/products/eyetect.html -
Mytear HARD LENS WETTING SOLUTION | OTC Products, etc. | Products | SENJU Pharmaceutical
Designated quasi-drugs Mytear® HARD LENS WETTING SOLUTION Lubricates lenses, allows smooth insertion CHARACTERISTICS Viscous liquid forms a thin layer on the surface of hard or rigid gas permeable len
http://www.senju.co.jp/english/products/wettingsolution.html